Cargando…

Optimization of the precursor supply for an enhanced FK506 production in Streptomyces tsukubaensis

Tacrolimus (FK506) is a macrolide widely used as immunosuppressant to prevent transplant rejection. Synthetic production of FK506 is not efficient and costly, whereas the biosynthesis of FK506 is complex and the level produced by the wild type strain, Streptomyces tsukubaensis, is very low. We there...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Susann, Schall, Christoph, Stehle, Thilo, Breitmeyer, Christian, Krysenko, Sergii, Mitulski, Agnieszka, Wohlleben, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715595/
https://www.ncbi.nlm.nih.gov/pubmed/36466343
http://dx.doi.org/10.3389/fbioe.2022.1067467
_version_ 1784842485925675008
author Schulz, Susann
Schall, Christoph
Stehle, Thilo
Breitmeyer, Christian
Krysenko, Sergii
Mitulski, Agnieszka
Wohlleben, Wolfgang
author_facet Schulz, Susann
Schall, Christoph
Stehle, Thilo
Breitmeyer, Christian
Krysenko, Sergii
Mitulski, Agnieszka
Wohlleben, Wolfgang
author_sort Schulz, Susann
collection PubMed
description Tacrolimus (FK506) is a macrolide widely used as immunosuppressant to prevent transplant rejection. Synthetic production of FK506 is not efficient and costly, whereas the biosynthesis of FK506 is complex and the level produced by the wild type strain, Streptomyces tsukubaensis, is very low. We therefore engineered FK506 biosynthesis and the supply of the precursor L-lysine to generate strains with improved FK506 yield. To increase FK506 production, first the intracellular supply of the essential precursor lysine was improved in the native host S. tsukubaensis NRRL 18488 by engineering the lysine biosynthetic pathway. Therefore, a feedback deregulated aspartate kinase AskSt* of S. tsukubaensis was generated by site directed mutagenesis. Whereas overexpression of AskSt* resulted only in a 17% increase in FK506 yield, heterologous overexpression of a feedback deregulated AskCg* from Corynebacterium glutamicum was proven to be more efficient. Combined overexpression of AskCg* and DapASt, showed a strong enhancement of the intracellular lysine pool following increase in the yield by approximately 73% compared to the wild type. Lysine is coverted into the FK506 building block pipecolate by the lysine cyclodeaminase FkbL. Construction of a ∆fkbL mutant led to a complete abolishment of the FK506 production, confirming the indispensability of this enzyme for FK506 production. Chemical complementation of the ∆fkbL mutant by feeding pipecolic acid and genetic complementation with fkbL as well as with other lysine cyclodeaminase genes (pipAf, pipASt, originating from Actinoplanes friuliensis and Streptomyces pristinaespiralis, respectively) completely restored FK506 production. Subsequently, FK506 production was enchanced by heterologous overexpression of PipAf and PipASp in S. tsukubaensis. This resulted in a yield increase by 65% compared to the WT in the presence of PipAf from A. friuliensis. For further rational yield improvement, the crystal structure of PipAf from A. friuliensis was determined at 1.3 Å resolution with the cofactor NADH bound and at 1.4 Å with its substrate lysine. Based on the structure the Ile91 residue was replaced by Val91 in PipAf, which resulted in an overall increase of FK506 production by approx. 100% compared to the WT.
format Online
Article
Text
id pubmed-9715595
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97155952022-12-03 Optimization of the precursor supply for an enhanced FK506 production in Streptomyces tsukubaensis Schulz, Susann Schall, Christoph Stehle, Thilo Breitmeyer, Christian Krysenko, Sergii Mitulski, Agnieszka Wohlleben, Wolfgang Front Bioeng Biotechnol Bioengineering and Biotechnology Tacrolimus (FK506) is a macrolide widely used as immunosuppressant to prevent transplant rejection. Synthetic production of FK506 is not efficient and costly, whereas the biosynthesis of FK506 is complex and the level produced by the wild type strain, Streptomyces tsukubaensis, is very low. We therefore engineered FK506 biosynthesis and the supply of the precursor L-lysine to generate strains with improved FK506 yield. To increase FK506 production, first the intracellular supply of the essential precursor lysine was improved in the native host S. tsukubaensis NRRL 18488 by engineering the lysine biosynthetic pathway. Therefore, a feedback deregulated aspartate kinase AskSt* of S. tsukubaensis was generated by site directed mutagenesis. Whereas overexpression of AskSt* resulted only in a 17% increase in FK506 yield, heterologous overexpression of a feedback deregulated AskCg* from Corynebacterium glutamicum was proven to be more efficient. Combined overexpression of AskCg* and DapASt, showed a strong enhancement of the intracellular lysine pool following increase in the yield by approximately 73% compared to the wild type. Lysine is coverted into the FK506 building block pipecolate by the lysine cyclodeaminase FkbL. Construction of a ∆fkbL mutant led to a complete abolishment of the FK506 production, confirming the indispensability of this enzyme for FK506 production. Chemical complementation of the ∆fkbL mutant by feeding pipecolic acid and genetic complementation with fkbL as well as with other lysine cyclodeaminase genes (pipAf, pipASt, originating from Actinoplanes friuliensis and Streptomyces pristinaespiralis, respectively) completely restored FK506 production. Subsequently, FK506 production was enchanced by heterologous overexpression of PipAf and PipASp in S. tsukubaensis. This resulted in a yield increase by 65% compared to the WT in the presence of PipAf from A. friuliensis. For further rational yield improvement, the crystal structure of PipAf from A. friuliensis was determined at 1.3 Å resolution with the cofactor NADH bound and at 1.4 Å with its substrate lysine. Based on the structure the Ile91 residue was replaced by Val91 in PipAf, which resulted in an overall increase of FK506 production by approx. 100% compared to the WT. Frontiers Media S.A. 2022-11-18 /pmc/articles/PMC9715595/ /pubmed/36466343 http://dx.doi.org/10.3389/fbioe.2022.1067467 Text en Copyright © 2022 Schulz, Schall, Stehle, Breitmeyer, Krysenko, Mitulski and Wohlleben. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Schulz, Susann
Schall, Christoph
Stehle, Thilo
Breitmeyer, Christian
Krysenko, Sergii
Mitulski, Agnieszka
Wohlleben, Wolfgang
Optimization of the precursor supply for an enhanced FK506 production in Streptomyces tsukubaensis
title Optimization of the precursor supply for an enhanced FK506 production in Streptomyces tsukubaensis
title_full Optimization of the precursor supply for an enhanced FK506 production in Streptomyces tsukubaensis
title_fullStr Optimization of the precursor supply for an enhanced FK506 production in Streptomyces tsukubaensis
title_full_unstemmed Optimization of the precursor supply for an enhanced FK506 production in Streptomyces tsukubaensis
title_short Optimization of the precursor supply for an enhanced FK506 production in Streptomyces tsukubaensis
title_sort optimization of the precursor supply for an enhanced fk506 production in streptomyces tsukubaensis
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715595/
https://www.ncbi.nlm.nih.gov/pubmed/36466343
http://dx.doi.org/10.3389/fbioe.2022.1067467
work_keys_str_mv AT schulzsusann optimizationoftheprecursorsupplyforanenhancedfk506productioninstreptomycestsukubaensis
AT schallchristoph optimizationoftheprecursorsupplyforanenhancedfk506productioninstreptomycestsukubaensis
AT stehlethilo optimizationoftheprecursorsupplyforanenhancedfk506productioninstreptomycestsukubaensis
AT breitmeyerchristian optimizationoftheprecursorsupplyforanenhancedfk506productioninstreptomycestsukubaensis
AT krysenkosergii optimizationoftheprecursorsupplyforanenhancedfk506productioninstreptomycestsukubaensis
AT mitulskiagnieszka optimizationoftheprecursorsupplyforanenhancedfk506productioninstreptomycestsukubaensis
AT wohllebenwolfgang optimizationoftheprecursorsupplyforanenhancedfk506productioninstreptomycestsukubaensis